COVID-19 Updates

Visit UC San Diego's Coronavirus portal for the latest information for the campus community.

Dr. Andrew Wiseman Named Director of Corporate Business Development

September 6, 2011 - The CTRI and Health Sciences are pleased to announce that, after a nationwide recruitment, Andrew Wiseman, PhD has been named Director of Corporate Business Development for UC San Diego Health Sciences.

Dr. Wiseman has extensive experience in business development for the pharmaceutical and biotech industries. He has held management positions at several local firms, including La Jolla Pharmaceutical Company, which focused on new drugs for antibody-mediated autoimmune diseases such as lupus. He was a founding member of that company’s management team, and served as Senior Director of Investor Relations. Dr. Wiseman had prior research experience at Cal Tech and Scripps Clinic and Research Foundation, where he investigated human mitochondrial genetics and disease. Both his undergraduate degree in Zoology and his doctoral degree in Genetics were obtained at Duke University.

As Director of Corporate Business Development, Dr. Wiseman will improve UC San Diego Health Sciences’ interactions with industry and expand our portfolio of private sponsored research. He will report to Dr. Gary S. Firestein, Dean and Associate Vice Chancellor, Translational Medicine and Director, CTRI. Working closely with Dr. Firestein and other Health Sciences leaders, Dr. Wiseman will head efforts to build Health Sciences’ corporate partnerships. These collaborations will involve translational medicine, research, and education with a variety of new and established partners, including corporate, government, academic, and health care organizations. Such strategic alliances will promote UCSD Health Sciences both nationally and internationally.

“Dr. Wiseman has particular strength in building and implementing highly effective programs in business development, investor relations, and medical marketing,” said Dr. Firestein. “His skills will be especially valuable as the CTRI and Health Sciences continue to fulfill their missions in an era of declining federal funding.”

Please join us in welcoming Dr. Wiseman.

About UC San Diego Altman Clinical and Translational Research Institute:

UC San Diego Altman Clinical and Translational Research Institute (ACTRI) is part of a national Clinical and Translational Science Award consortium, led by the National Institutes of Health National Center for Advancing Translational Science. Established in 2010, ACTRI provides infrastructure and support for basic, translational and clinical research throughout the San Diego region to bring discoveries from the laboratory to the bedside, and facilitates training and education of the next generation of researchers. ACTRI carries out its activities in collaboration with institutional and corporate partners and currently has more than 1,500 members.